Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01233050 · ClinicalTrials.gov registry record · NA
Efficacy Comparison of Two Preoperative Skin Antisepsis Preparations in Colorectal Surgery
A NA study of Colorectal Surgery, sponsored by University of Pennsylvania.
- Completed
- Registry status
- NA
- Development phase
- 802
- Enrollment target
- 3
- Study locations
NCT01233050 is a NA study of Colorectal Surgery that has completed, run by University of Pennsylvania. The registered enrollment target is 802 participants, above the 230-participant average among 8 other Colorectal Surgery trials with a reported enrollment target (249% higher). The trial reports 3 study locations across 1 state.
The verdict
NCT01233050, a NA study of Colorectal Surgery, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- NA
- Development phase
- 802 participants
- Enrollment target
- 3
- Study locations
Study Summary
Surgical site infections (SSI) are one of the most common complications in the post-operative patient, and the second most common health care associated infection overall. It is estimated that there are between 500 thousand and 1.1 million surgical site infections in the United States each year. Given the magnitude of the problem, prevention of surgical site infections is a major goal of peri-operative care. However, skin preparation prior to surgery has not been as rigorously examined. The primary objective of this study is to compare the efficacy of two FDA approved, popular peri-operative skin preparations 2% chlorhexidine gluconate / 70% isopropyl alcohol to Iodine Povacrylex \[0.7% available Iodine\] / 74% Isopropyl Alcohol in the prevention of superficial surgical site infection. Male and female patients, age 18 years and older undergoing elective colorectal surgical procedures involving a laparotomy will be enrolled. These patients are at high risk of SSI. Eligible patients will be assessed at regular intervals for SSI and characterization of bacterial pathogen(s) in patients with SSI. Patients will remain enrolled into the study until 35 days postoperatively.
Conditions Studied
Interventions
- DRUG 2% Chlorhexidine Gluconate/70% Isopropyl Alcohol
- DRUG Iodine Povacrylex/74% Isopropyl Alcohol
Study Locations (3)
Pennsylvania
- Hospital of the University of Pennsylvania - Philadelphia
- Penn Presbyterian Medical Center - Philadelphia
- Pennsylvania Hospital - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 802 participants |
| Start Date | 2010-12 |
| Est. Completion | 2015-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01233050
The ClinicalTrials.gov registry entry for NCT01233050 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 802 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 230-participant average among 8 other Colorectal Surgery trials with a reported enrollment target (249% higher). The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Colorectal Surgery appearing as the primary indexed condition, and to 2 interventions - of which 2% Chlorhexidine Gluconate/70% Isopropyl Alcohol is the first listed.
NCT01233050 reports 3 study locations spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT01233050 about?
NCT01233050 is a clinical study titled "Efficacy Comparison of Two Preoperative Skin Antisepsis Preparations in Colorectal Surgery". Surgical site infections (SSI) are one of the most common complications in the post-operative patient, and the second most common health care associated infection overall. It is estimated that there are between 500 thousand and 1.1 million surgical site infections in the United States each year. Giv...
What is the current status of trial NCT01233050?
This trial is currently completed. It is a NA study. The enrollment target is 802 participants. The study started on 2010-12. Estimated completion is 2015-02.
What conditions does trial NCT01233050 study?
This clinical trial studies the following conditions: Colorectal Surgery.
What interventions are being tested in trial NCT01233050?
The interventions under investigation include: 2% Chlorhexidine Gluconate/70% Isopropyl Alcohol (DRUG), Iodine Povacrylex/74% Isopropyl Alcohol (DRUG).
Who is sponsoring clinical trial NCT01233050?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01233050 being conducted?
This trial has 3 study locations across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Colorectal Surgery
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Safety and Effectiveness Evaluation of the COLO-BT as an Alternative Treatment to the Ileostomy
RECRUITING · NA
-
Duration of Urinary Catheterization
RECRUITING · NA
-
A Safety and Effectiveness Prospective Blinded Clinical Study to Validate xBar System as Monitoring Tool for Anastomotic Leaks Detection
RECRUITING · NA
-
A Trial of Adding Lung Protective Strategies to Existing Enhanced Recovery After Surgery (ERAS) Protocols and Its Effects on Improving Post-Operative Lung Function
COMPLETED · NA
-
COMPRES - COMpression Anastomosis Ring (CAR™ 27/ColonRing™) Post maRketing Evaluation Study
COMPLETED · Phase 4
-
Application to Improve Patient Engagement and Decrease Postoperative Opioid Consumption in Patients for Colorectal Surgery
COMPLETED
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.